Veterinary Clinical Reference

Look up any drug or condition.

Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.

209 evergreen hubsCited at every claimContinuously updatedFree for verified vets
ReptileJul 15, 2026

Reptile Dysecdysis: A Clinical Approach to Abnormal Shedding in Snakes, Lizards, and Chelonians

Dysecdysis (abnormal or incomplete shedding) in reptiles is almost always a sign of a husbandry or systemic-health failure rather than a primary skin disease. This hub reviews the ecdysis cycle, the husbandry and disease causes, diagnosis, and taxon-specific management including retained spectacles in snakes and constricting digit and tail-tip bands in geckos and lizards for the exotic and small-animal clinician.

Read →
Guinea PigJul 15, 2026

Guinea Pig Pregnancy Toxemia (Ketosis): A Clinical Reference for Veterinarians

Pregnancy toxemia is a peracute, often fatal metabolic and circulatory disease of the late-gestation or immediately postpartum guinea pig sow, with a grave prognosis once clinical. This reference covers the two overlapping forms (ketotic and preeclampsia-like), the non-pregnant fasting form, signalment and risk factors, clinical signs, clinicopathology, aggressive supportive dosing, and the prevention strategy that actually changes outcomes.

Read →
FerretJul 15, 2026

Ferret Hyperestrogenism: Estrogen Toxicity in the Intact Jill

Persistent estrus in the intact jill drives hyperestrogenism and estrogen-induced marrow suppression — a potentially fatal pancytopenia. This hub covers the induced-ovulation pathophysiology, CBC/PCV-based prognosis, how to bring the jill out of estrus (hCG, GnRH, deslorelin implant), stabilization and ovariohysterectomy, prevention, and the adrenal-disease differential in the spayed ferret.

Read →
ReptileJul 14, 2026

Reptile Dystocia and Egg Binding: A Clinical Reference for Veterinarians

Reptile dystocia splits into pre-ovulatory follicular stasis (an ovarian problem in which follicles fail to ovulate or resorb) and post-ovulatory egg stasis (shelled eggs formed but not passed), which is further divided into obstructive and non-obstructive disease. This distinction, made on radiographs and ultrasound, dictates management: non-obstructive post-ovulatory cases may respond to husbandry correction, fluids, calcium, and oxytocin, whereas obstruction, pre-ovulatory follicular stasis, and failed medical therapy are surgical. Oxytocin is reasonably effective in chelonians and many lizards but unreliable in snakes, and it is contraindicated when mechanical obstruction is present.

Read →
RabbitJul 14, 2026

Rabbit Uterine Adenocarcinoma: Signalment, Staging, and the Ovariohysterectomy Decision

Uterine adenocarcinoma is the most common tumor of intact female rabbits. A DVM reference on age- and breed-related prevalence, the hematuria-to-metastasis clinical course, staging with thoracic radiographs, why ovariohysterectomy is curative only before metastasis, and evidence-based spay timing.

Read →
Guinea PigJul 14, 2026

Guinea Pig Ovarian Cysts (Cystic Ovarian Disease): A Veterinary Clinical Reference

Cystic ovarian disease is the most common reproductive disorder of intact guinea pig sows, with ultrasonographic prevalence exceeding two-thirds in animals over three years. This clinical reference reviews the serous (rete ovarii) versus follicular cyst distinction, ultrasound-led diagnosis, concurrent uterine pathology, and the honest evidence behind ovariohysterectomy, deslorelin, hCG, and cyst drainage — plus guinea pig-specific perioperative and antibiotic cautions.

Read →
Guinea PigJul 14, 2026

Antibiotic-Associated Dysbiosis and Enterotoxemia in Guinea Pigs

A prevention-first drug-safety reference on antibiotic-associated dysbiosis and clostridial enterotoxemia in guinea pigs and other hindgut fermenters: which antibiotic classes are contraindicated, which are flora-sparing, the route nuances, and how to recognize and manage iatrogenic enterotoxemia.

Read →
ChinchillaJul 14, 2026

Acquired Dental Disease in Chinchillas: Diagnosis and Treatment

Acquired dental disease is a leading cause of morbidity in pet chinchillas, driven by inadequate dietary abrasion of their continuously growing (aradicular hypsodont) incisors and cheek teeth. This clinical reference reviews the anatomy and pathophysiology, the clinical signs, why diagnosis requires skull radiographs or CT plus an oral examination under general anesthesia, and evidence-based treatment: crown reduction with a dental burr, analgesia, assisted feeding, prokinetics, and correction of the diet to unlimited grass hay.

Read →
AvianJul 14, 2026

Egg Binding and Dystocia in Pet Birds: A Veterinary Clinical Reference

Egg binding (failure to pass an egg within the normal interval) and dystocia (mechanical obstruction of oviposition) are common, life-threatening emergencies in small psittacines such as cockatiels, budgerigars, and lovebirds. This reference covers definitions, hypocalcemia and husbandry risk factors, radiographic diagnosis, and the evidence-based treatment ladder from stabilization and parenteral calcium through PGE2 gel, oxytocin, ovocentesis, and salpingohysterectomy.

Read →
AvianJul 14, 2026

Avian Aspergillosis in Birds: Aspergillus fumigatus Pathogenesis, Diagnosis, and Antifungal Treatment

A clinical reference on avian aspergillosis for veterinarians: how Aspergillus fumigatus causes opportunistic respiratory and systemic disease in psittacines, raptors, waterfowl, and penguins; why presentation is insidious; how to combine endoscopy, imaging, hematology, and serology for diagnosis; and evidence-based antifungal dosing — including the reduced itraconazole dose required in African grey parrots and voriconazole's species-specific toxicity.

Read →
CanineJul 13, 2026

Sileo (Dexmedetomidine Oromucosal Gel) for Canine Noise Aversion: Dosing, Efficacy, and Safety

Sileo (dexmedetomidine oromucosal gel) is the first and only FDA-approved treatment for canine noise aversion — an alpha-2 agonist absorbed transmucosally, dosed by weight as syringe "dots" and given shortly before or at the onset of an anticipated noise event. This hub covers label dosing, the pivotal RCT, adverse effects, contraindications, and where it sits against trazodone, clonidine, tasipimidine, and daily SSRIs.

Read →
CanineJul 13, 2026

Clonidine for Dogs: Off-Label Alpha-2 Agonist for Noise Aversion, Storm Phobia, and Situational Anxiety

Clonidine is a human alpha-2 adrenergic agonist used off-label in dogs as a short-acting, event-based adjunct for situational fear and anxiety — noise aversion, storm phobia, separation-related distress, fear reactivity, and vet-visit anxiety — layered on a daily SSRI or TCA plus behavior modification rather than run as standalone monotherapy. This hub summarizes the off-label dosing (~0.01–0.05 mg/kg PO), the limited open-label efficacy evidence, adverse effects, contraindications and interactions, and where clonidine sits relative to the FDA-approved event drug dexmedetomidine oromucosal gel (Sileo), trazodone, and gabapentin.

Read →